Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Downgrades Toromont Industries Ltd (TIH:CN) (TMTNF) to Hold
-
Canaccord Genuity Downgrades Ivanhoe Mines Ltd. (IVN:CN) (IVPAF) to Spec. Buy
-
Canaccord Genuity Downgrades Rogers Communications (RCI/B:CN) (RCI) to Hold
-
Canaccord Genuity Upgrades BCE Inc. (BCE:CN) (BCE) to Buy
-
Greenlane Announces Closing of $48.25 Million Convertible Note Financing
-
Canaccord Genuity Downgrades Quarterhill Inc. (QTRH:CN) (QTRH) to Hold
-
Canaccord Genuity Starts Homology Medicines (FIXX) at Buy
-
IQE plc: Chief Financial Officer appointment: confirmation of start date
-
Canaccord Genuity Upgrades Artis REIT (AX-U:CN) (ARESF) to Buy
-
Selecta Biosciences (SELB) PT Lowered to $25 at Canaccord Genuity
-
Qualcomm kicks off crucial fight with U.S. antitrust regulator
-
Canaccord Genuity Starts Chembio Diagnostics (CEMI) at Buy
-
Canaccord Genuity Downgrades Celgene (CELG) to Hold
-
UPDATE: 'Speculative Bullish' Options Activity in Snap (SNAP) into Early February Earnings Announcement, Amid Notable Short Interest -Susquehanna
-
Qualcomm (QCOM) Well Positioned Into 5G, Settlements - Canaccord Genuity
-
Apple (AAPL) PT Lowered to $190 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Upgrades Alphabet (GOOGL) to Buy
-
EastWest Bioscience Appoints High Profile Retail Management Advisory Team
-
Snap Inc (SNAP) PT Lowered to $6.25 at Canaccord Genuity
-
Facebook (FB) PT Lowered to $180 at Canaccord Genuity
-
Facebook (FB) PT Lowered to $180 at Canaccord Genuity
-
Twitter, Inc. (TWTR) PT Lowered to $32 at Canaccord Genuity
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $44 at Canaccord Genuity
-
Canaccord Genuity Starts Paratek Pharmaceuticals (PRTK) at Buy
-
Canaccord Genuity Starts Insmed (INSM) at Buy
-
Green Growth Brands Reaffirms Aphria (APHA) Takeover Bid
-
Green Growth Brands Reaffirms Commitment to Takeover Aphria Inc.
-
Total voting rights
-
TransGlobe Energy Corporation Announces Changes to the Executive Management Team and Board of Directors
-
Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
-
Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
-
Green Growth to launch hostile bid for pot producer Aphria
-
Harpoon Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Anglo Pacific Group PLC announces Dividend Timetable
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholding
-
CSE: 2018-1225 – New Listing - Scotch Creek Ventures Inc. (SCV)
-
Histogenics (HSGX) Says FDA Indicated Additional Trial Needed to Complete Submission of BLA for NeoCart
-
Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway
-
Anglo Pacific Group PLC Announces Directors' and PDMR's Share Dealings in Company
-
Anglo Pacific Group PLC Announces Directors' and PDMR's Share Dealings in Company
-
Mene Inc. Announces Closing of Funding Round
-
1933 Industries Announces First Quarter 2019 Financials
-
Patriot One Provides Corporate Update
-
Canaccord Genuity Downgrades Civitas Solutions (CIVI) to Hold
-
TransGlobe Energy Corporation Announces Director/PDMR Shareholding
-
Ninepoint Partners Announces Ninepoint 2019 Flow-Through Limited Partnership
-
Allergan's Woes Offering an Opportunity for Sientra (SIEN) - Canaccord Genuity
-
Wayland Group to Explore Strategic Alternatives to Maximize Shareholder Value Including the Spinout and/or European Listing of its International Assets
-
Canaccord Genuity Starts Spark Networks (LOV) at Buy
-
CMP 2019 Resource Limited Partnership Files Preliminary Prospectus

